<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">25544508</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>10</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1471-2156</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>15</Volume>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Dec</Month>
                        <Day>29</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC genetics</Title>
                <ISOAbbreviation>BMC Genet.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population.</ArticleTitle>
            <Pagination>
                <MedlinePgn>156</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12863-014-0156-x</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Several pathogenesis and genetic factors influence predisposition to antituberculosis drug-induced hepatotoxicity (ATDH) especially for isoniazid (INH). However, the major susceptibility genes for ATDH are N-acetyltransferase 2 (NAT2) and cytochrome P450 2E1 (CYP2E1). NAT2 gene determines the individual's acetylator status (fast, intermediate or slow) to metabolize drugs and xenobiotics, while CYP2E1 c1/c1 genotype carriers had an increased risk of ATDH. Polymorphisms of the NAT2 and CYP2E1 genes vary remarkably among the populations of different ethnic origins. The aim of this study was to determine, for the first time, the frequency of slow acetylators in Moroccan population by genotyping of NAT2 gene variants and determining the genotype c1/c1 for CYP2E1 gene, in order to predict adverse effects of Tuberculosis treatment, particularly hepatotoxicity.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The frequencies of specific NAT2 alleles were 53%, 25%, 2% and 4% for NAT2*5, NAT2*6, NAT2*7 and NAT2*14 respectively among 163 Moroccan studied group. Genotyping of CYP2E1 gene, by real-time polymerase chain reaction using TaqMan probes, revealed frequencies of 98.5% for c1/c1 and 1.5% for c1/c2 among 130 Moroccan studied group.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The most prevalent genotypes of NAT2 gene in Moroccans are those which encode slow acetylation phenotype (72.39%), leading to a high risk of ATDH. Most Moroccans are homozygous for c1 allele of CYP2E1 gene which aggravates hepatotoxicity in slow acetylators. This genetic background should be taken into account in determining the minimum dose of INH needed to treat Moroccan TB patients, in order to decrease adverse effects.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Guaoua</LastName>
                    <ForeName>Soukaina</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre de génomique humaine, Faculté de médecine et de pharmacie, Université Mohammed V, Rabat, Morocco. soukainaguaoua@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ratbi</LastName>
                    <ForeName>Ilham</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre de génomique humaine, Faculté de médecine et de pharmacie, Université Mohammed V, Rabat, Morocco. i.ratbi@um5s.net.ma.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Laarabi</LastName>
                    <ForeName>Fatima Zahra</ForeName>
                    <Initials>FZ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Département de génétique médicale, Institut National d'Hygiène, Rabat, Morocco. fz_laarabi@yahoo.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Elalaoui</LastName>
                    <ForeName>Siham Chafai</ForeName>
                    <Initials>SC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre de génomique humaine, Faculté de médecine et de pharmacie, Université Mohammed V, Rabat, Morocco. sihamgen@yahoo.fr.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Département de génétique médicale, Institut National d'Hygiène, Rabat, Morocco. sihamgen@yahoo.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jaouad</LastName>
                    <ForeName>Imane Cherkaoui</ForeName>
                    <Initials>IC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre de génomique humaine, Faculté de médecine et de pharmacie, Université Mohammed V, Rabat, Morocco. imane_cj@yahoo.fr.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Département de génétique médicale, Institut National d'Hygiène, Rabat, Morocco. imane_cj@yahoo.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barkat</LastName>
                    <ForeName>Amina</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre National de Référence en Néonatologie et en Nutrition, Rabat, Morocco. barakatamina@hotmail.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sefiani</LastName>
                    <ForeName>Abdelaziz</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre de génomique humaine, Faculté de médecine et de pharmacie, Université Mohammed V, Rabat, Morocco. sefianigen@hotmail.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Département de génétique médicale, Institut National d'Hygiène, Rabat, Morocco. sefianigen@hotmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>12</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMC Genet</MedlineTA>
            <NlmUniqueID>100966978</NlmUniqueID>
            <ISSNLinking>1471-2156</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.14.13.-</RegistryNumber>
                <NameOfSubstance UI="D019392">Cytochrome P-450 CYP2E1</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.3.1.5</RegistryNumber>
                <NameOfSubstance UI="D001191">Arylamine N-Acetyltransferase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.3.1.5</RegistryNumber>
                <NameOfSubstance UI="C478900">NAT2 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>V83O1VOZ8L</RegistryNumber>
                <NameOfSubstance UI="D007538">Isoniazid</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000995" MajorTopicYN="N">Antitubercular Agents</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001191" MajorTopicYN="N">Arylamine N-Acetyltransferase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056486" MajorTopicYN="N">Chemical and Drug Induced Liver Injury</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019392" MajorTopicYN="N">Cytochrome P-450 CYP2E1</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007538" MajorTopicYN="N">Isoniazid</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009018" MajorTopicYN="N">Morocco</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>05</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>12</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>12</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>12</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>10</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25544508</ArticleId>
            <ArticleId IdType="doi">10.1186/s12863-014-0156-x</ArticleId>
            <ArticleId IdType="pii">s12863-014-0156-x</ArticleId>
            <ArticleId IdType="pmc">PMC4299568</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Pharmacogenetics. 1994 Jun;4(3):125-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7920692</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mem Inst Oswaldo Cruz. 2011 Sep;106(6):716-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22012226</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Pharmacol. 2013 May;69(5):1091-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23150149</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tuberculosis (Edinb). 2006 Sep;86(5):374-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16246623</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacogenetics. 1996 Jun;6(3):257-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8807666</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 2003 Jun;55(6):560-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12814450</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bull Cancer. 2006 Mar 1;93(3):297-302</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16567317</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Exp Biol. 2003 Nov;41(11):1226-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15332488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol Hepatol. 2006 Apr;21(4):784-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16677176</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Alcohol. 2001 Feb;23(2):91-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11331106</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Clin Pharmacol Ther. 2002 Dec;40(12):548-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12503812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1985 May 25;260(10):6385-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3997827</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacogenetics. 1995 Oct;5(5):298-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8563770</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Drug Saf. 2006 Mar;5(2):231-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16503745</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2002 Oct 1;166(7):916-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12359646</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacogenetics. 2001 Apr;11(3):207-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11337936</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Sci Res Med Sci. 2003 Aug;5(1-2):9-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24019729</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2006 Oct 15;174(8):935-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17021358</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Exp Ther. 1985 Dec;235(3):566-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4078724</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacogenomics. 2010 Sep;11(9):1205-6; author reply 1207-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20860460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 2000 Sep 1;87(5):734-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10925369</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dev Ctries. 2012 Sep;6(9):671-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23000867</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 1975 Jul;18(1):70-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1149365</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 1976 Feb;84(2):181-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">766682</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Tuberc Lung Dis. 2007 Aug;11(8):868-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17705952</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genomics. 1993 Dec;18(3):702-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8307581</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Toxicol Environ Health B Crit Rev. 2009;12(5-6):362-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20183527</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Carcinogenesis. 2007 Aug;28(8):1665-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17434923</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2003 Apr;37(4):924-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12668988</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Genet. 2008;9:21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18304320</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 1997 May;155(5):1717-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9154882</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Tuberc Lung Dis. 2000 Mar;4(3):256-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10751073</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol Lett. 2004 Jun 15;151(1):273-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15177663</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol Hepatol. 2008 Feb;23(2):192-202</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17995946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Otolaryngol Head Neck Surg. 2011 Oct;145(4):586-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21705789</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1239-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11751440</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>